Halo Labs Inc (NEO:HALO) (OTCMKTS:AGEEF) (FRA:A9KN) Chief Revenue Officer David Orr joins Midas Letter in Los Angeles, California to discuss the company's strategic direction. While the cannabis derivative industry has been becoming increasingly more competitive, Halo Labs has managed to distinguish themselves from the mass of brands with innovations within the portable 'dabbing' world, through commercialization of its Shatterizer and DabTabs vapourizer products. DabTabs are ceramic based tablets that allow customers to customize their desired dosage. DabTabs can be filled with live resin, shatter, distillate in any concentration of CBD and THC. Among other developments, Halo Labs' is also expanding across the United States, Europe and Latin America. A large focus of the Chief Revenue Officer is the large potential revenue streams stemming from the company's expertise in cannabis extraction and providing quality white label products for others. Mr. Orr explains when analyzing the company's financials and business streams coupled with its expertise and knowledge in extractions, the company is undervalued in comparison to its peers. ************************ Check out our website: https://midasletter.com ************************ SUBSCRIBE to our YouTube: http://bit.ly/MidasLetterYoutube SUBSCRIBE to our 2nd YouTube Channel - Midas Letter Clips: https://bit.ly/2rtQzgy SUBSCRIBE to our Newsletter: http://bit.ly/MidasLetterNewsletter Download Our Podcast on iTunes: http://bit.ly/MidasLetterPodcast ************************ Follow Us on Twitter: http://bit.ly/MidasLetterTwitter Like Us on Instagram: http://bit.ly/MidasLetterInsta Like Us on Facebook: http://bit.ly/MidasLetterFacebook ************************ #WeedStocks #MidasLetter
George Scorsis Liberty Health Sciences
Originally posted on Halo Labs Inc (NEO:HALO) Undervalued Extractor's Strategic Direction via George Scorsis Medical Marijuana News
No comments:
Post a Comment